Early research (Phase 1)Study completedNCT00937872
What this trial is testing
A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects
Who this might be right for
Diabetes Mellitus, Type 2
Sirtris, a GSK Company 9